France
· Delayed Price · Currency is EUR AB Science Statistics
Total Valuation
AB Science has a market cap or net worth of EUR 75.89 million. The enterprise value is 86.38 million.
| Market Cap | 75.89M |
| Enterprise Value | 86.38M |
Important Dates
The next estimated earnings date is Tuesday, September 30, 2025.
| Earnings Date | Sep 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AB Science has 65.43 million shares outstanding. The number of shares has increased by 5.12% in one year.
| Current Share Class | 59.37M |
| Shares Outstanding | 65.43M |
| Shares Change (YoY) | +5.12% |
| Shares Change (QoQ) | +2.01% |
| Owned by Insiders (%) | 31.27% |
| Owned by Institutions (%) | 0.86% |
| Float | 23.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 70.80 |
| PB Ratio | -3.20 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 205.12 |
| P/OCF Ratio | 144.56 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.03 |
| EV / Sales | 80.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 233.46 |
Financial Position
The company has a current ratio of 0.71
| Current Ratio | 0.71 |
| Quick Ratio | 0.66 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 49.92 |
| Interest Coverage | -5.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -15.62% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -221.85% |
| Revenue Per Employee | 31,529 |
| Profits Per Employee | -230,324 |
| Employee Count | 57 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.26% in the last 52 weeks. The beta is 1.57, so AB Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.57 |
| 52-Week Price Change | -7.26% |
| 50-Day Moving Average | 1.35 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 36.74 |
| Average Volume (20 Days) | 156,480 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AB Science had revenue of EUR 1.07 million and -7.83 million in losses. Loss per share was -0.15.
| Revenue | 1.07M |
| Gross Profit | 1.25M |
| Operating Income | -6.08M |
| Pretax Income | -7.83M |
| Net Income | -7.83M |
| EBITDA | -5.69M |
| EBIT | -6.08M |
| Loss Per Share | -0.15 |
Balance Sheet
The company has 7.99 million in cash and 18.47 million in debt, giving a net cash position of -10.48 million or -0.16 per share.
| Cash & Cash Equivalents | 7.99M |
| Total Debt | 18.47M |
| Net Cash | -10.48M |
| Net Cash Per Share | -0.16 |
| Equity (Book Value) | -23.75M |
| Book Value Per Share | -0.37 |
| Working Capital | -5.91M |
Cash Flow
In the last 12 months, operating cash flow was 525,000 and capital expenditures -155,000, giving a free cash flow of 370,000.
| Operating Cash Flow | 525,000 |
| Capital Expenditures | -155,000 |
| Free Cash Flow | 370,000 |
| FCF Per Share | 0.01 |
Margins
| Gross Margin | 116.42% |
| Operating Margin | -567.44% |
| Pretax Margin | -730.50% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | 34.51% |
Dividends & Yields
AB Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.12% |
| Shareholder Yield | n/a |
| Earnings Yield | -10.32% |
| FCF Yield | 0.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |